A cost-utility analysis of clopidogrel in patients with non-ST-segment-elevation acute coronary syndromes in the UK.

@article{Karnon2006ACA,
  title={A cost-utility analysis of clopidogrel in patients with non-ST-segment-elevation acute coronary syndromes in the UK.},
  author={Jon Karnon and Ameet Bakhai and Amanda Brennan and Abdullah Pandor and Marcus Flather and Emma Warren and David Gray and Ron L. Akehurst},
  journal={International journal of cardiology},
  year={2006},
  volume={109 3},
  pages={
          307-16
        }
}
OBJECTIVE To assess the long-term cost effectiveness of 1 year's treatment with clopidogrel on top of standard therapy (including aspirin; ASA) compared with standard therapy alone, in patients diagnosed with non-ST-segment-elevation acute coronary syndromes (ACS) in the UK. DESIGN Cost utility analysis using a Markov model, incorporating clinical data from CURE (a multicentre randomised controlled trial, involving 12,562 patients) and data from UK observational studies. SETTING Health… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 20 CITATIONS

A critique and impact analysis of decision modeling assumptions.

  • Medical decision making : an international journal of the Society for Medical Decision Making
  • 2007
VIEW 3 EXCERPTS
CITES METHODS & BACKGROUND

Clopidogrel versus Aspirin in Patients with Atherothrombosis

  • Applied Health Economics and Health Policy
  • 2012
VIEW 2 EXCERPTS
CITES BACKGROUND